Vivos Therapeutics Inc
NASDAQ:VVOS
Vivos Therapeutics Inc
Pre-Tax Income
Vivos Therapeutics Inc
Pre-Tax Income Peer Comparison
Competitive Pre-Tax Income Analysis
Latest Figures & CAGR of Competitors
Company | Pre-Tax Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Vivos Therapeutics Inc
NASDAQ:VVOS
|
Pre-Tax Income
-$13.6m
|
CAGR 3-Years
-4%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
N/A
|
|
DaVita Inc
NYSE:DVA
|
Pre-Tax Income
$1.3B
|
CAGR 3-Years
0%
|
CAGR 5-Years
7%
|
CAGR 10-Years
0%
|
|
Quest Diagnostics Inc
NYSE:DGX
|
Pre-Tax Income
$1.1B
|
CAGR 3-Years
-22%
|
CAGR 5-Years
4%
|
CAGR 10-Years
-2%
|
|
CVS Health Corp
NYSE:CVS
|
Pre-Tax Income
$9.9B
|
CAGR 3-Years
0%
|
CAGR 5-Years
39%
|
CAGR 10-Years
2%
|
|
Cigna Corp
NYSE:CI
|
Pre-Tax Income
$4B
|
CAGR 3-Years
-29%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
3%
|
|
Laboratory Corporation of America Holdings
NYSE:LH
|
Pre-Tax Income
$594m
|
CAGR 3-Years
-45%
|
CAGR 5-Years
-14%
|
CAGR 10-Years
-4%
|
See Also
What is Vivos Therapeutics Inc's Pre-Tax Income?
Pre-Tax Income
-13.6m
USD
Based on the financial report for Dec 31, 2023, Vivos Therapeutics Inc's Pre-Tax Income amounts to -13.6m USD.
What is Vivos Therapeutics Inc's Pre-Tax Income growth rate?
Pre-Tax Income CAGR 5Y
-10%
Over the last year, the Pre-Tax Income growth was 43%. The average annual Pre-Tax Income growth rates for Vivos Therapeutics Inc have been -4% over the past three years , -10% over the past five years .